Evidence map›Paper›PMID 33108790›Full record

ArticleNeuroendocrinology2021

Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death.

Sami Matrood, Nicola de Prisco, Thaddeus T Wissniowski, Dominik Wiese, Samir Jabari, Heidi Griesmann, Michael Wanzel, Thorsten Stiewe, Daniel Neureiter, Eckhard Klieser and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Neuroendocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Sami MatroodDepartment of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany.
Nicola de PriscoDepartments of Genetics and Development, Pediatrics and Neurology, Columbia University Irving Medical Center, New York, New York, USA.
Thaddeus T WissniowskiDepartment of Gastroenterology, Philipps University Marburg, Marburg, Germany.
Dominik WieseDepartment of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany.
Samir JabariInstitute of Anatomy I, University of Erlangen-Nuremberg, Erlangen, Germany.
Heidi GriesmannDepartment of Internal Medicine I, University Hospital Halle (Saale), Halle (Saale), Germany.
Michael WanzelInstitute for Molecular Oncology, Member of the German Center for Lung Research, Philipps University Marburg, Marburg, Germany.
Thorsten StieweInstitute for Molecular Oncology, Member of the German Center for Lung Research, Philipps University Marburg, Marburg, Germany.
Daniel NeureiterInstitute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria.
Eckhard KlieserInstitute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Salzburg, Austria.
Ioannis MintzirasDepartment of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany.
Malte BuchholzDepartment of Gastroenterology, Philipps University Marburg, Marburg, Germany.
Detlef K BartschDepartment of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany.
Vincenzo A GennarinoDepartments of Genetics and Development, Pediatrics and Neurology, Columbia University Irving Medical Center, New York, New York, USA.
Pietro Di FazioDepartment of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany, difazio@med.uni-marburg.de.
Philipps University of Marburg · DEColumbia University Irving Medical Center · USGerman Center for Lung Research · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEParacelsus Medical University · ATSalzburger Landeskliniken · ATUniversity Hospital in Halle · DE

Funding

Deciphering the Role of the Pumilio1 in Two Distinct Neurological DiseasesR01NS109858 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Vincenzo Alessandro Gennarino · 2019 to 2026
$4.1M
NINDS NIH HHS R01 NS109858
6 · The paper itself

Abstract

introductionAutophagic cell death in cancer cells can be mediated by inhibition of deacetylases. Although extensive studies have focused on the autophagic process in cancer, little is known about the role of autophagy in degrading cytosolic and nuclear components of pancreatic neuroendocrine neoplastic (pNEN) cells leading to cell death, thus improving the therapy of patients affected by pNEN.

methods2D and 3D human pNEN and pancreatic stellate cells were treated with panobinostat and bafilomycin. Autophagy markers were detected by RT-qPCR, immunofluorescence, and Western blot. Autophagosomes were detected by electron microscopy and their maturation by real-time fluorescence of LC3B stable transfected cells. ChIP was performed at the cAMP responsive element. Immunofluorescence was performed in murine pancreatic tissue.

resultsWe observed that pan-deacetylase inhibitor panobinostat treatment causes autophagic cell death in pNEN cells. We also found that although AMPK-α phosphorylation is counterbalanced by phosphorylated AKT, it is not capable to inhibiting autophagic cell death. However, the binding activity of the cAMP responsive element is prompted by panobinostat. Although autophagy inhibition prevented autophagosome synthesis, maturation, and cell death, panobinostat treatment induced the accumulation of mature autophagosomes in the cytosol and the nucleus, leading to disruption of the organelles, cellular digestion, and decay. Observation of autophagosome membrane proteins Beclin1 and LC3B aggregation in murine pancreatic islets indicates that autophagy restoration may also lead to autophagosome aggregation in murine insulinoma cells. A basal low expression of autophagy markers was detectable in patients affected by pNEN, and, interestingly, the expression of these markers was significantly lower in metastatic pNEN. DISCUSSION/

conclusionOur study highlights that the autophagy functional restoration and prolongation of this catabolic process, mediated by inhibition of deacetylase, is responsible for the reduction of pNEN cells. Prompting of autophagy cell death could be a promising strategy for the therapy of pNEN.

Indexed as

Autophagic Cell DeathCell Line, TumorEnzyme InhibitorsHumansNeuroendocrine TumorsPancreatic NeoplasmsPanobinostatEnzyme InhibitorsPanobinostatActivated protein kinaseAutophagyCell deathInsulinomaPancreatic neuroendocrine cancerSpheroids

Identifiers

PMID33108790
PMCPMC11905116
OpenAlexW3097597947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.